Article metrics
ABSTRACTS: PLENARY SESSIONS: Session 2 – Breast and Uterine Sarcoma
BASELINE BREAST CANCER RISK DEMOGRAPHICS AND METHODOLOGY FOR THE RALOXIFENE USE FOR THE HEART (RUTH) AND CONTINUING OUTCOMES RELEVANT TO EVISTA (CORE) STUDIES, TWO BREAST CANCER PREVENTION TRIALS